Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

544 ARTÍCULOS , VIENDO DEL 346 AL 360

Aging in a highly polluted world: challenges and solutions to prevent Alzheimer's disease

Domingo JL.

Arch Toxicol. 2026 Aug;100(8):3293-3314. doi: 10.1007/s00204-026-04469-x. Epub 2026 Jun 8.

Large-scale EEG network alterations in late-onset epilepsy of unknown etiology: A comparative study with Alzheimer's disease

Wan H, Chen Y, Zhang X, Yu Z, Zheng K, Shao X, Bi M, Jiang B, Wang Z.

Neurobiol Dis. 2026 Sep;227:107483. doi: 10.1016/j.nbd.2026.107483. Epub 2026 Jun 10.

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression

da Silva AMP, Tudella GCN, Gonçalves OR, Ribeiro FV, Pereira MAOM, do Nascimento MDVS, Nogueira BV, Santos DH, de Gobbi Porto FH, Høilund-Carlsen PF, Duarte FS, Perry G, de Souza Franco E, de Sousa Maia MB.

Drugs. 2026 Jul;86(7):1103-1119. doi: 10.1007/s40265-026-02335-9. Epub 2026 May 27.

A reappraisal of APOE genetic effects on Alzheimer's disease risk in the Japanese population: a meta-analysis

Miyashita A, Hara N, Obinata A, Tsukie T, Hasegawa M, Ishiguro T, Kasuga K, Kikuchi M, Hashimoto T, Kanekiyo T, Ikeuchi T.

Mol Neurodegener. 2026 Jun 24;21(1):33. doi: 10.1186/s13024-026-00963-z.

Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome

Marta-Ariza M, Wisniewski T.

Expert Rev Neurother. 2026 Aug;26(8):745-763. doi: 10.1080/14737175.2026.2695187. Epub 2026 Jun 29.

Reduced diffusion associated with amyloid-related imaging abnormalities in three patients treated with donanemab

Schwartz NU, Dietz CD, Lin Z, Tammewar G, Bui N, La Joie R, Wang Y, Sreekrishnan A, Suhami D, VandeVrede L, Ljubenkov PA, Rojas JC.

Neurocase. 2026 Aug;32(4):174-179. doi: 10.1080/13554794.2026.2695021. Epub 2026 Jul 2.

Osteoimmuno-brain axis: a bridge connecting osteoporosis and cognitive decline and its clinical significance in dementia and Alzheimer's disease

Xu G, Cheng Z, Zhou Y, Guo L, Zhu H, Shen Z.

Front Immunol. 2026 Jun 24;17:1866071. doi: 10.3389/fimmu.2026.1866071. eCollection 2026.

The Role of Genetic Alterations in the Emergence of Alzheimer's Disease in Down Syndrome: A Review

Robles CV, Robles CV, Revilla APA, de Jesús Valencia Suárez V, Santander MAS.

Eur J Neurosci. 2026 Jul;64(1):e70623. doi: 10.1111/ejn.70623.

Changes in cortical plasticity induced by paired associative stimulation in people with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

Fu X, Niu X, Lin X, He W, Liao C, Xin T, Li S, Wang SX, Liu JQJ, Li B, Cheng J.

Front Neural Circuits. 2026 Jun 29;20:1853684. doi: 10.3389/fncir.2026.1853684. eCollection 2026.

Disruption of temporo-parietal network in Alzheimer's disease and its association with memory impairment

Suksangkharn Y, Schott BH, Zeidman P, Vockert N, Lattmann R, Schütze H, Yakupov R, Peters O, Hellmann-Regen J, Preis L, Ersözlü E, Priller J, Spruth EJ, Beckmann J, Schneider A, Fliessbach K, Wiltfang J, Bartels C, Rostamzadeh A, Glanz W, Incesoy EI, Teipel S, Kilimann I, Goerss D, Laske C, Spottke A, Kronmüller M, Brosseron F, Lüsebrink F, Schmid M, Kleineidam L, Stark M, Hetzer S, Dechent P, Jessen F, Maass A, Düzel E, Ziegler G.

Alzheimers Res Ther. 2026 Jul 15;18(1):166. doi: 10.1186/s13195-026-02138-w.

Passive amyloid-β immunotherapy in Alzheimer's disease: a multicellular clearance system beyond plaque removal

Zhan X, Liu C, Yu C, Lindblom N, Deierborg T, Kobro-Flatmoen A, Gouras GK, Wen G.

Mol Neurodegener. 2026 Jul 16;21(1):37. doi: 10.1186/s13024-026-00972-y.

Standardizing care for agitation in Alzheimer's disease, results from a randomized controlled trial of an integrated care pathway versus usual care - the StaN trial

Kumar S, Burhan AM, Colman S, Chu L, Davies S, Derkach P, Elmi S, Gerretsen P, Graff-Guerrero A, Greenway K, Hussain M, Ismail Z, Kim D, Krisman L, Ma C, Moghabghab R, Mulsant BH, Pollock BG, Rej S, Rostas A, Schoer N, Streiner DL, Van Bussel L, Rajji TK; StaN Study Group.

Alzheimers Dement. 2026 Jul;22(7):e71610. doi: 10.1002/alz.71610.

Non-transgenic rodent models associated with Alzheimer's disease: applications, evaluations, and perspectives

Xing S, Ren P, Chen Z, Fu Y.

Neuroscience. 2026 Sep 28;612:335-358. doi: 10.1016/j.neuroscience.2026.07.063. Epub 2026 Jul 28.

BACH1/HO-1 axis dysregulation links Down syndrome to Alzheimer-like neurodegeneration

Di Domenico F, Barone E, Perluigi M.

Neurochem Int. 2026 Oct;199:106232. doi: 10.1016/j.neuint.2026.106232. Epub 2026 Jul 30.

The role of polygenic risk in Alzheimer's disease prediction for African Americans

Hutten CG, Beck T, Evans D, Rajan KB.

Alzheimers Dement. 2026 Aug;22(8):e71712. doi: 10.1002/alz.71712.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias